Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156650
Status:
COMPLETED
Last Update Posted:
2008-09-19
First Post:
2005-09-08
Brief Title:
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone HOP 5 Testicular Aspiration Addendum
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Male Hormonal Contraception Development Suppression of Spermatogenesis With the Addition of a Potent GnRH Antagonist Acyline to Testosterone and DMPA ACY-5 -Sub-Study HOP 5
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IHOP-5
Brief Summary:
This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated Participation is voluntary
The purpose of this added procedure Testicular Aspiration-HOP 3 is to determine the amount of testosterone male hormone in the testes of men who are on a male contraceptive regimen
The purpose of this added procedure Testicular Aspiration-HOP 3 is to determine the amount of testosterone male hormone in the testes of men who are on a male contraceptive regimen
Detailed Description:
The goal of our contraception study ACY-5 is to develop a hormonal regimen where in all individuals enrolled achieve azoospermia zero sperm However early data demonstrated that some individuals have persistent sperm in their semen despite treatment We hope to be able to determine whether differences in intratesticular hormone levels account for persistent sperm production in men who do not reach counts of zero as compared to those who do in the male contraceptive study This study will measure testosterone levels in the testes of men who are participating in male contraceptive studies Testosterone will be measured in a small amount of testicular fluid at the end of the study treatment phase after sperm counts have been reduced to zero or very low levels
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U54HD042454 | NIH | None | httpsreporternihgovquickSearchU54HD042454 |